Country Risk Report Q4 2021 - Academic

Covid-19 mRNA vaccine booster outlook positive despite heart inflammation risk

Pfizer drew headlines this month when it raised the idea of an emergency authorization for its COVID-19 mRNA vaccine booster to combat the Delta variant. But what does this mean for its rare heart inflammation side effects?


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.